Karen Makishima

Papers

Total Citations

H-Index

About

Karen Makishima is a urologic oncologist whose research focuses on improving outcomes for prostate cancer patients, particularly through the refinement of surgical techniques and prognostic indicators. Her most-cited work, a 2021 study on the impact of positive surgical margin status in predicting early biochemical recurrence after robot-assisted radical prostatectomy, has garnered 24 citations and provides critical insights into postoperative risk stratification. This contribution helps surgeons and patients better understand the implications of margin status on recurrence, guiding more personalized follow-up and treatment decisions. Makishima’s research bridges the gap between surgical precision and long-term oncologic control, emphasizing the role of robotic surgery in minimizing complications while maximizing cancer clearance. Her work is part of a broader effort to enhance predictive models for biochemical recurrence, a key endpoint in prostate cancer management. By integrating clinical outcomes with surgical pathology, Makishima advances the field of urologic oncology, offering evidence that directly informs clinical practice and patient counseling. Her dedication to data-driven surgical care underscores her impact on improving survival and quality of life for men with prostate cancer.